380 related articles for article (PubMed ID: 19785054)
1. Targeting innate immune pathways in cancer immunotherapy: state of the art.
Mastellos DC
J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
[TBL] [Abstract][Full Text] [Related]
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
3. Immune cells as anti-cancer therapeutic targets and tools.
Johansson M; Tan T; de Visser KE; Coussens LM
J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
[TBL] [Abstract][Full Text] [Related]
4. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
5. Complement as effector system in cancer immunotherapy.
Macor P; Tedesco F
Immunol Lett; 2007 Jul; 111(1):6-13. PubMed ID: 17572509
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
7. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
8. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
Mocellin S; Rossi CR; Nitti D
Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tumor immunity by therapeutic monoclonal antibodies.
Abès R; Teillaud JL
Cancer Metastasis Rev; 2011 Mar; 30(1):111-24. PubMed ID: 21267767
[TBL] [Abstract][Full Text] [Related]
10. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.
Bronte V; Cingarlini S; Marigo I; De Santo C; Gallina G; Dolcetti L; Ugel S; Peranzoni E; Mandruzzato S; Zanovello P
Immunol Invest; 2006; 35(3-4):327-57. PubMed ID: 16916757
[TBL] [Abstract][Full Text] [Related]
12. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
Mocellin S; Nitti D
Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
[TBL] [Abstract][Full Text] [Related]
13. Targeting costimulatory pathways for tumor immunotherapy.
Ward RC; Kaufman HL
Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
[TBL] [Abstract][Full Text] [Related]
14. Complement: central to innate immunity and bridging to adaptive responses.
Morgan BP; Marchbank KJ; Longhi MP; Harris CL; Gallimore AM
Immunol Lett; 2005 Mar; 97(2):171-9. PubMed ID: 15752555
[TBL] [Abstract][Full Text] [Related]
15. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.
Knutson KL; Disis ML
Cancer Immunol Immunother; 2005 Aug; 54(8):721-8. PubMed ID: 16010587
[TBL] [Abstract][Full Text] [Related]
16. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects.
Alvarez-Pellitero P
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):171-98. PubMed ID: 18783835
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
Jinushi M; Hodi FS; Dranoff G
Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
[TBL] [Abstract][Full Text] [Related]
18. Complement and its role in innate and adaptive immune responses.
Dunkelberger JR; Song WC
Cell Res; 2010 Jan; 20(1):34-50. PubMed ID: 20010915
[TBL] [Abstract][Full Text] [Related]
19. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial cancer immunotherapy.
Hodi FS; Dranoff G
Adv Immunol; 2006; 90():341-68. PubMed ID: 16730268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
